Feasibility of the absolute quantification and left ventricular segmentation of cardiac sympathetic innervation in wild-type transthyretin amyloidosis cardiomyopathy with [123I]-MIBG SPECT/CT: The I-NERVE study

Authors

Riemer H. J. A. Slart (ORCID: https://orcid.org/0000-0002-5565-1164)
Walter Noordzij (ORCID: https://orcid.org/0000-0001-6386-5499)
Hans Nienhuis (ORCID: https://orcid.org/0000-0003-3974-6830)
Oleksandra Ivashchenko (ORCID: https://orcid.org/0000-0001-8675-8987)
Andor W.J.M. Glaudemans (ORCID: https://orcid.org/0000-0001-8081-0641)
Alwin Tubben (ORCID: https://orcid.org/0000-0001-8414-958X)
Niek H. J. Prakken (ORCID: https://orcid.org/0000-0001-7043-3336)
Hendrea S. A. Tingen (ORCID: https://orcid.org/0000-0002-8572-9428)
Peter van der Meer (ORCID: https://orcid.org/0000-0002-9705-4413)

Institutions

University Medical Center Groningen (NL)
University of Groningen (NL)

Publication Details

Journal: Journal of Nuclear Cardiology
Published: 2025-02-03
DOI: https://doi.org/10.1016/j.nuclcard.2025.102146
Citations: 4
Primary Topic: Amyloidosis: Diagnosis, Treatment, Outcomes
Type: article
Field-Weighted Citation Impact: 3.22

Funders

Pfizer
Pfizer Pharmaceuticals

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Feasibility of the absolute quantification and left ventricular segmentation of cardiac sympathetic innervation in wild-type transthyretin amyloidosis cardiomyopathy with [123I]-MIBG SPECT/CT: The I-NERVE study

Riemer H. J. A. Slart, Walter Noordzij, Hans Nienhuis, Oleksandra Ivashchenko et al.

Feb 3, 2025

4 citations

Journal of Nuclear Cardiology

Amyloidosis: Diagnosis, Treatment, Outcomes

3.22

article

Feasibility of the absolute quantification and left ventricular segmentation of cardiac sympathetic innervation in wild-type transthyretin amyloidosis cardiomyopathy with [123I]-MIBG SPECT/CT: The I-NERVE study

Riemer H. J. A. Slart, Walter Noordzij, Hans Nienhuis, Oleksandra Ivashchenko, Andor W.J.M. Glaudemans, Alwin Tubben, Niek H. J. Prakken, Hendrea S. A. Tingen, Peter van der Meer

February 3, 2025article en

4 citations

Abstract

No abstract available for this paper.

Journal of Nuclear CardiologyVol. 45

University Medical Center Groningen (NL), University of Groningen (NL)

Pfizer, Pfizer Pharmaceuticals

Zero hunger

Openalex Percentile: Top 9%

Amyloidosis: Diagnosis, Treatment, Outcomes

3.22

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Feasibility of the absolute quantification and left ventricular segmentation of cardiac sympathetic innervation in wild-type transthyretin amyloidosis cardiomyopathy with [123I]-MIBG SPECT/CT: The I-NERVE study — Riemer H. J. A. Slart, Walter Noordzij, et al. · Journal of Nuclear Cardiology (2025) | TGRS Research Map | TGRS